Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

1.ETHICAL GUIDELINES

Authorship
Authors submitting a paper must have the manuscript read and approved by all authors.
All authors must agree to the submission of the manuscript to the Journal in its current form.

The International Cairo Dental Journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). According to the ICMJE authorship criteria should be based on 1) substantial contributions to conception and design of, or acquisition of data or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content and 3) final approval of the version to be published. Authors must meet all 3 conditions. Contributors who do not qualify as authors should be mentioned under acknowledgements.


All email addresses for all co-authors must be submitted with the manuscript. If any of the email-addresses supplied are incorrect the corresponding author will be contacted by the journal administrator. 

Ethical Approvals
Experimentation involving human subjects will only be published if such research has been conducted in full accordance with ethical principles, including the World Medical Association Declaration of Helsinki (version 2008) and the additional requirements, if any, of the country where the research has been carried out. Manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each subject and a statement regarding the fact that the study has been independently reviewed and approved by an ethical board should also be included.

When experimental animals are used the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations.

All studies using human or animal subjects should include an explicit statement in the Material and Methods section identifying the review and ethics committee approval for each study, if applicable. Editors reserve the right to reject papers if there is doubt as to whether appropriate procedures have been used.

Clinical Trials
Clinical trials should be reported using the CONSORT guidelines available at www.consort-statement.org. A CONSORT checklist should also be included in the submission material.

Authors submitting manuscripts are required to register the trials in any free, public clinical trials registries recognized by the World health organization. The clinical trial registration number and name of the trial register will be published with the paper.

DNA Sequences and Crystallographic Structure Determinations
Papers reporting protein or DNA sequences and crystallographic structure determinations will not be accepted without a Genbank or Brookhaven accession number, respectively. Other supporting data sets must be made available on the publication date from the authors directly.

Conflict of Interest and Source of Funding
All authors (both the corresponding author and co-authors) must disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author’s objectivity is considered a potential source of conflict of interest and must be reported. If authors are unsure whether a past or present affiliation or relationship should be disclosed in the manuscript, please contact the editorial office at hani.elnahass@dentistry.cu.edu.eg. The existence of a conflict of interest does not preclude publication in this journal.

The above policies are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals produced by the International Committee of Medical Journal Editors (http://www.icmje.org/). It is the responsibility of the corresponding author to have all authors of a manuscript fill out a conflict of interest disclosure form, and to upload all forms together with the manuscript on submission. The disclosure statement should be included under Acknowledgements.

Appeal of Decision
Under exception circumstances, authors may appeal the editorial decision. Authors who wish to appeal the decision on their submitted paper may do so by e-mailing the editorial office at hani.elnahass@dentistry.cu.edu.eg with a detailed explanation for why they find reasons to appeal the decision.

Please note that all revisions and resubmissions of papers should also include a separate rebuttal and a tracked changes document to assist in peer review.

Permissions
If all or parts of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author's responsibility to obtain these in writing and provide copies to the Publishers.

 

2.MANUSCRIPT SUBMISSION

Blinded Review
All manuscripts submitted to The International Cairo Dental Journal will be reviewed by two or more experts in the field. Papers that do not conform to the general aims and scope of the journal will, however, be returned immediately without review. The names of the reviewers will not be disclosed to the author submitting a paper.

 

E-mail Confirmation of Submission
After submission you will receive an e-mail to confirm receipt of your manuscript. If you do not receive the confirmation e-mail after 48 hours, please check your e-mail address carefully before contacting the editorial office.

 

Manuscript Files Accepted
Main manuscripts should be uploaded as Word (.doc) or Rich Text Format (.rft) files (not write-protected). The text file must contain the entire manuscript including title page, abstract, clinical reference, main text, references, acknowledgement, statement of source of funding and any potential conflict of interest, tables, and figure legends, but no embedded figures.

Please ensure that ALL items (figures and tables) are cited in the main text.

Figure files should be sent separately to the main text.  GIF, JPEG, PICT or Bitmap files are acceptable for submission, but only high-resolution TIF or EPS files are suitable for printing.

Manuscripts should be formatted as described in the next section below.

3.MANUSCRIPT FORMAT AND STRUCTURE

5.1. Format

Language: The language of publication is English. Authors for whom English is a second language may choose to have their manuscript professionally edited before submission to improve the English.


Structure
All articles submitted to the Journal should include:

  • Title Page
  • Conflict of Interest and Source of Funding
  • Abstract
  • Introduction
  • Materials and Methods
  • Results
  • Discussion
  • References
  • Tables (where appropriate)
  • Figure Legends (where appropriate)
  • Figures (where appropriate and uploaded as separate files)

All manuscripts should emphasize clarity and avoid overt technical jargon. Authors should pay special attention to the presentation of their findings so that they may be communicated clearly to the readers.

Title Page: The title must be concise. The title page should include a running title of no more than 40 characters; 5-10 key words, complete names of institutions for each author, and the name, address, telephone number, fax number and e-mail address for the corresponding author.

Conflict of Interest and Source of Funding: Authors are required to disclose all sources of institutional, private and corporate financial support for their study. Suppliers of materials (for free or at a discount from current rates) should be named in the source of funding and their location (town, state/county, country) included. Other suppliers will be identified in the text. If no funding has been available other than that of the author’s institution, this should be specified upon submission. Author’s conflict of interest or information specifying the absence of conflicts of interest should be written as a statement under the title of conflict of interest and source of funding.

 

Abstract: is limited to 200 words in length and should not contain abbreviations or references. The abstract should be organized according to the content of the paper.

Acknowledgements: Under acknowledgements please specify contributors to the article other than the authors accredited.

**Original Research Articles

Main Text of Original Research Articles should be organized with

  • Introduction,
  • Materials and Methods,
  • Results and Discussion.
  • References (Harvard)

The word limit for original research articles is 3500 words, and up to 7 items (figures and tables) may be included. Additional items can be included as supplementary files.

Introduction: should be focused, outlining the origins of the study and not summarize the results; exhaustive literature reviews are not appropriate. It should close with the explicit statement of the specific aims of the investigation.


Material and Methods: must contain sufficient detail with references cited so that all clinical trials and experiments reported can be fully reproduced.

Clinical trials should be reported using the CONSORT guidelines. If your study is a randomized clinical trial, you will need to fill in all sections of the CONSORT Checklist. If your study is not a randomized trial, not all sections of the checklist might apply to your manuscript, in which case you simply fill in N/A.
The clinical trial registration number and name of the trial register will be published with the paper and should be mentioned in the materials and methods section.

For clinical trials intention to treat analyses are encouraged (the reasons for choosing other types of analysis should be highlighted in the submission letter and clarified in the manuscript).

All studies using human or animal subjects should include an explicit statement in the Material and Methods section identifying the review and ethics committee approval for each study, if applicable. Editors reserve the right to reject papers if there is doubt as to whether appropriate procedures have been used.

Results: should present the observations with minimal reference to earlier literature or to possible interpretations.

Discussion: may start with a brief summary of the major findings, but repetition should be avoided. The discussion section should end with a brief conclusion and a comment on the potential clinical relevance of the findings. Statements and interpretation of the data should be appropriately supported by original references.


**Reviews
Reviews are selected for their broad general interest. The use of state-of-the-art evidence-based systematic approaches is expected. The word limit for reviews is 4000 words.

The main text of Reviews should be organized with

  • Introduction,
  • Review of Current Literature,
  • Discussion and Conclusion
  • References (Harvard)

References

References should be prepared with a citation software and should follow Harvard style.


Tables, Figures and Figure Legends
Tables should be kept plain with single ruling, in black and white.

Figures should be arranged in the order they would appear in the final version. Unnecessary figures and panels of figures should be avoided.

Figures divided into parts should be labelled with a lower-case, boldface, roman letter, a, b, and so on, in the same type size as used elsewhere in the figure.
Although low quality images are adequate for review purposes, print publication requires high quality images to prevent the final product being blurred or fuzzy. Submit EPS (lineart) or TIFF (halftone/photographs) files only. MS PowerPoint and Word Graphics are unsuitable for printed pictures. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size. EPS files should be saved with fonts embedded (and with a TIFF preview if possible).

 

Figure Legends should be a separate section of the manuscript, and should begin with a brief title for the whole figure and continue with a short description of each panel and the symbols used; they should not contain any details of methods.

Copyright Assignment
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting to complete the license agreement on behalf of all authors on the paper.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.